Spectral waveform analysis of umbilical artery blood flow — placental resistance, S/D ratio, and the FGR surveillance cascade from elevated resistance to reversed end-diastolic flow
The umbilical artery carries deoxygenated, nutrient-depleted fetal blood from the fetal internal iliac arteries through the umbilical cord to the placenta. Its Doppler waveform is a direct, non-invasive window into downstream placental vascular resistance — a surrogate for the health of the tertiary stem villi that make up the functional exchange surface between mother and fetus. As pregnancy advances normally, angiogenesis progressively multiplies the villous capillary bed, and impedance to flow falls steadily, producing a waveform with prominent forward flow throughout systole AND diastole.
The umbilical artery waveform is generated by pulsed-wave Doppler insonation of a free loop of cord, angle-corrected as close to 0° as feasible. Because absolute flow velocity depends on vessel diameter and insonation angle — both difficult to standardize — clinicians use angle-independent ratio indices rather than raw velocities:
Systolic/Diastolic ratio (S/D) = Peak Systolic Velocity (PSV) / End-Diastolic Velocity (EDV) • Simplest index; drops toward 2.0–3.0 by term as resistance falls • Becomes null or non-numeric once EDV reaches zero — a key limitation
Pulsatility Index (PI) = (PSV − EDV) / Mean Velocity • Uses the time-averaged maximum velocity over the full cycle in the denominator • Remains mathematically defined even when EDV = 0 or reverses — preferred index for growth restriction surveillance because it can still be trended into severe disease
Resistance Index (RI, Pourcelot index) = (PSV − EDV) / PSV • Bounded between 0 and 1 for forward-flow states • Simple but loses discriminating power at very high resistance
All three indices reflect the same underlying phenomenon: the compliance and caliber of the distal placental vascular tree. A normally developed placenta with an extensive, low-resistance capillary bed lets blood run off into diastole almost as easily as during systole, so EDV stays high relative to PSV and all indices stay low. As gestational age advances from early second trimester to term, indices normally fall continuously — this is why interpretation always requires gestational-age-specific percentile charts, never a single fixed cutoff.
Umbilical artery Doppler is not a universal antenatal screening test; large randomized trials have not shown benefit when applied to unselected low-risk pregnancies. Its proven value is in the surveillance of pregnancies already identified as at risk for placental insufficiency:
• Fetal growth restriction (estimated fetal weight or abdominal circumference <10th percentile, especially <3rd) • Hypertensive disorders of pregnancy (preeclampsia, chronic hypertension with superimposed preeclampsia) • Prior stillbirth or FGR in a previous pregnancy • Suspected placental pathology on ultrasound (e.g. abnormal cord insertion, small placenta)
In these populations, multiple randomized controlled trials and a Cochrane meta-analysis demonstrate that incorporating umbilical artery Doppler into the surveillance protocol reduces perinatal mortality — one of the few antenatal fetal tests with this level of outcome evidence, in contrast to the NST and BPP which mainly reduce iatrogenic intervention without clearly proven mortality benefit on their own.
When placental villous vascular development is impaired — most commonly due to defective trophoblastic invasion of the maternal spiral arteries early in pregnancy — the tertiary villous capillary bed fails to expand normally. The result is a smaller-caliber, stiffer, higher-resistance vascular tree. The umbilical Doppler waveform responds by showing diminished (but still present) diastolic flow, and S/D, PI, and RI all rise above the gestational-age-specific 95th percentile.
Normal placentation depends on extravillous trophoblast cells invading the maternal spiral arteries in two waves (roughly 8–10 and 14–16 weeks), converting them from narrow, muscular, vasoreactive vessels into wide, flaccid, low-resistance conduits incapable of vasoconstriction. In many cases of FGR and preeclampsia, this invasion is shallow or incomplete — spiral arteries retain smooth muscle and vasoreactivity, intervillous perfusion is reduced, and the fetal placental vascular bed itself often shows a reduction in tertiary villi and terminal capillary loops ("villous hypovascularity" or, in advanced disease, obliterative changes).
Because the umbilical artery waveform is generated by the fetal (not maternal) side of the placental circulation, what it measures directly is impedance on the fetal placental vascular tree — which correlates with, but is not identical to, maternal spiral artery disease. This is why umbilical Doppler and uterine artery Doppler (which assesses the maternal side) are complementary rather than redundant tests, and are often obtained together in a comprehensive placental insufficiency work-up.
At this stage, obliteration of the tertiary villous vascular bed is estimated at roughly 30–60%. Diastolic flow is diminished but not yet absent — there is still runoff of blood into the umbilical circulation throughout the cardiac cycle, just less efficiently than normal.
An isolated finding of elevated S/D ratio/PI without absent or reversed flow generally does NOT mandate immediate delivery. Instead, management shifts to intensified surveillance:
• Umbilical artery Doppler repeated weekly (or per unit protocol) • Serial growth ultrasounds every 2–3 weeks to trend estimated fetal weight trajectory • Concurrent NST and/or biophysical profile, typically weekly to twice weekly • Addition of middle cerebral artery (MCA) Doppler to screen for brain-sparing physiology (see Stage 4) • Low-dose aspirin continuation if initiated for preeclampsia prophylaxis; blood pressure surveillance • Antenatal corticosteroids considered proactively if the pregnancy is preterm and trending toward possible early delivery
Delivery timing decisions at this stage are individualized, generally targeting late preterm to term (around 37 weeks) in isolated elevated-resistance FGR without other complicating features, but earlier if growth arrests, oligohydramnios develops, or the waveform progresses to AEDF/REDF.
Elevated S/D ratio alone, in the absence of absent/reversed end-diastolic flow, growth restriction, or oligohydramnios, is a soft marker — it should prompt closer surveillance, not automatic delivery. The trajectory of change over serial exams matters as much as any single value.
Absent end-diastolic flow (AEDF) describes a waveform in which forward flow velocity falls completely to the zero baseline at end-diastole, even though brisk systolic flow persists. This is not a subtle finding — it is a qualitative change readily seen on the spectral display — and it corresponds to a substantially more advanced degree of placental vascular obliteration than simple elevated resistance.
Doppler modeling and histopathologic correlation studies (Trudinger, Giles and others) established that end-diastolic flow does not disappear gradually in proportion to resistance — it behaves more like a threshold phenomenon. Approximately 60–70% of the tertiary villous vascular bed must be obliterated before net forward flow at end-diastole reaches zero. Below that threshold, EDV falls but remains measurably positive (Stage 2); once obliteration crosses the threshold, the fetal heart can no longer generate enough pressure to sustain forward flow against placental impedance during the low-pressure diastolic phase, and flow ceases entirely at that point in the cycle.
This matters clinically because it means AEDF is never an incidental or borderline finding — by the time it appears, the placental vascular reserve has already been substantially and often irreversibly compromised.
AEDF materially raises the risk of adverse perinatal outcome (acidemia, stillbirth, neonatal morbidity) compared to elevated resistance alone, and management responds accordingly:
• Doppler and fetal heart rate surveillance typically increase to twice weekly or more; many units admit for inpatient monitoring depending on gestational age and associated findings • Daily or near-daily assessment of amniotic fluid volume and fetal well-being once the pregnancy approaches a gestational age where delivery would be considered • Antenatal corticosteroids for fetal lung maturity should be administered promptly if the pregnancy is preterm (typically <34 weeks) and has not already received a course, given that progression to REDF or non-reassuring testing can occur abruptly • Delivery is generally recommended once AEDF is confirmed and the pregnancy has reached approximately 33–34 weeks, sooner if additional non-reassuring findings (abnormal CTG, oligohydramnios, maternal deterioration) are present; expectant management with intensive surveillance is sometimes pursued at earlier gestational ages if the fetus otherwise remains stable, balancing risks of extreme prematurity against ongoing placental compromise • Delivery mode is individualized; AEDF with a non-reassuring tracing or very preterm gestation often favors cesarean delivery given limited fetal reserve to tolerate labor
Reversed end-diastolic flow (REDF) occurs when, at end-diastole, blood in the umbilical artery actually moves backward — away from the fetus and toward the placenta — rather than merely stopping. It represents the most severe end of the umbilical artery Doppler spectrum and is strongly associated with severe placental vascular obliteration, fetal acidemia, and a markedly elevated risk of stillbirth if the pregnancy is allowed to continue.
REDF results when placental impedance becomes so high that the pressure gradient reverses during diastole — the elastic recoil of proximal arterial segments pushes blood backward into the low-pressure, high-resistance distal bed rather than allowing continued forward runoff. This is essentially a windkessel effect operating against a near-occluded downstream circuit.
REDF is strongly associated with severe fetal growth restriction, oligohydramnios, and abnormalities on other surveillance modalities (non-reactive NST, abnormal biophysical profile, abnormal ductus venosus Doppler showing absent or reversed a-wave — reflecting downstream cardiac decompensation). Umbilical venous pulsations may also appear, another sign of significant cardiovascular compromise. The interval from AEDF to REDF, and from REDF to stillbirth or severe acidemia if untreated, can be short — sometimes days — which is why REDF triggers urgent rather than routine intensified management.
Because of the high risk of stillbirth associated with REDF, most maternal-fetal medicine protocols (consistent with SMFM/ACOG-aligned guidance) recommend delivery once REDF is confirmed and the fetus has reached a gestational age at which survival is considered reasonable — commonly cited thresholds are delivery by approximately 30–32 weeks with REDF, and consideration of even earlier delivery if additional non-reassuring findings are present, after balancing against extreme prematurity risk with the neonatology team.
Practical management sequence once REDF is identified:
• Immediate hospital admission for continuous or near-continuous fetal heart rate monitoring • Antenatal corticosteroids given emergently if not already completed and gestational age permits • Magnesium sulfate for fetal neuroprotection if <32 weeks and delivery is anticipated • Multidisciplinary planning with neonatology given anticipated preterm, growth-restricted neonate • Cesarean delivery is favored in most REDF cases, particularly at earlier gestational ages, given minimal fetal reserve to tolerate the additional stress of labor
Below the threshold of viability, REDF poses a profound counseling challenge, and management is individualized with extensive family counseling regarding prognosis.
REDF is one of the few antenatal findings where the default clinical posture shifts from "monitor and reassess" to "plan delivery" — the natural history without intervention carries a substantial risk of stillbirth, and expectant management beyond completion of steroids (and, if indicated, magnesium) is rarely justified once the fetus has reached a viable, resuscitation-appropriate gestational age.
Middle cerebral artery (MCA) Doppler assesses cerebral vascular resistance. In the presence of chronic hypoxemia from placental insufficiency, the fetus preferentially redistributes cardiac output to the brain, heart, and adrenal glands at the expense of other organs — the "brain-sparing effect." This lowers cerebral vascular resistance and therefore lowers the MCA pulsatility index below normal.
The Cerebroplacental Ratio (CPR) = MCA-PI / UA-PI combines both vascular territories into a single index. A CPR below the gestational-age-specific 5th percentile (roughly <1.0 in many reference ranges) indicates redistribution and is associated with an increased risk of adverse perinatal outcome, intrapartum fetal compromise, and operative delivery for non-reassuring fetal status — even in fetuses whose umbilical artery Doppler alone is only mildly abnormal or whose growth is near-normal (so-called "late FGR" with normal UA Doppler but abnormal CPR).
CPR is particularly useful in term or late-preterm suspected FGR, where umbilical Doppler abnormalities are often subtle or absent but brain-sparing physiology can still identify fetuses at meaningfully higher risk — making CPR an important adjunct rather than a replacement for umbilical artery Doppler in a comprehensive surveillance strategy.